Provided by Tiger Fintech (Singapore) Pte. Ltd.

GENSCRIPT BIO

16.950
-0.260-1.51%
Volume:21.07M
Turnover:356.77M
Market Cap:36.97B
PE:1.55
High:17.290
Open:17.000
Low:16.760
Close:17.210
52wk High:18.960
52wk Low:8.880
Shares:2.18B
HK Float Shares:2.18B
Volume Ratio:1.07
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(LYR):10.961
ROE:-5.46%
ROA:0.13%
PB:1.09
PE(LYR):1.55
PS:7.92

Loading ...

Legend Biotech Corporation Names Peter Salovey as Lead Independent Director

Reuters
·
Jun 05

Genscript Biotech's Myeloma Drug Shows Progression-Free Survival in One-Third of Patients During Study

MT Newswires Live
·
Jun 04

Legend Biotech Announces Promising Phase 1 Results for LB2102 CAR-T Therapy in Lung Cancer Patients

Reuters
·
Jun 03

Legend Biotech to Reveal New CARVYKTI Data for Multiple Myeloma at 2025 ASCO and EHA Meetings

Reuters
·
May 23

Legend Biotech Corporation to Host Investor Event During American Society of Clinical Oncology Annual Meeting

Reuters
·
May 19

BUZZ-Legend Biotech slips after brokerages cut PT

Reuters
·
May 14

Legend Biotech USA Inc. Signs Lease for New Global Headquarters in Bridgewater, New Jersey

Reuters
·
May 14

Legend Biotech Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Legend Biotech Reports Q1 2025: Net Loss Widens to $100.9M, License Revenue Falls by $2.9M, CARVYKTI® Sales Reach $369M

Reuters
·
May 13

Legend Biotech Corp expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
May 10

Genscript Biotech Associate Logs $369 Million in Q1 Sales of CARVYKTI

MT Newswires Live
·
Apr 16

Genscript Biotech Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
Apr 10

Hong Kong Stocks Reverse Early Losses to End Higher; Pharma Stocks Slide

MT Newswires Live
·
Apr 09

Hong Kong Pharma Stocks Decline as Trump Threatens Tariffs on Imported Drugs

MT Newswires Live
·
Apr 09

Further weakness as Genscript Biotech (HKG:1548) drops 3.1% this week, taking three-year losses to 52%

Simply Wall St.
·
Mar 14

Press Release: GenScript Biotech Corporation Reports FY 2024 Results

Dow Jones
·
Mar 12

Genscript Biotech Swings to Profit in 2024; Shares Down 4%

MT Newswires Live
·
Mar 12

BUZZ-Legend Biotech gains on narrower Q4 loss

Reuters
·
Mar 11

Legend Biotech Corp expected to post a loss of 33 cents a share - Earnings Preview

Reuters
·
Mar 07

Genscript Biotech Expects Higher 2024 Net Profit

MT Newswires Live
·
Feb 17